Öztop, H.; Hunutlu, F.Ç.; Ekizoğlu, S.İ.; Gül, Ö.Ö.; Cander, S.; Şahin, A.B.
Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors. J. Clin. Med. 2025, 14, 1306.
https://doi.org/10.3390/jcm14041306
AMA Style
Öztop H, Hunutlu FÇ, Ekizoğlu Sİ, Gül ÖÖ, Cander S, Şahin AB.
Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors. Journal of Clinical Medicine. 2025; 14(4):1306.
https://doi.org/10.3390/jcm14041306
Chicago/Turabian Style
Öztop, Hikmet, Fazıl Çağrı Hunutlu, Selin İldemir Ekizoğlu, Özen Öz Gül, Soner Cander, and Ahmet Bilgehan Şahin.
2025. "Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors" Journal of Clinical Medicine 14, no. 4: 1306.
https://doi.org/10.3390/jcm14041306
APA Style
Öztop, H., Hunutlu, F. Ç., Ekizoğlu, S. İ., Gül, Ö. Ö., Cander, S., & Şahin, A. B.
(2025). Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors. Journal of Clinical Medicine, 14(4), 1306.
https://doi.org/10.3390/jcm14041306